IMVT
USDImmunovant Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$23.380
High
$24.530
Low
$23.310
Volume
1.45M
Company Fundamentals
Market Cap
4.2B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.71M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.
Truist Securities Initiates Coverage On Immunovant with Hold Rating, Announces Price Target of $16
Truist Securities analyst Danielle Brill initiates coverage on Immunovant with a Hold rating and announces Price Target of $16.
Related Stocks
TDC
Teradata Corporation
WEN
Wendy's Company (The)
OXLCP
Oxford Lane Capital Corp. 6.25% Series 2027 Term Preferred Shares
VRNA
Verona Pharma plc American Depositary Share
SWKS
Skyworks Solutions Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.